Cubresa Inc. Their vision is to become the global leader in optimizing drug selection, dosing, and monitoring through innovative imaging solutions. Cubresa's products enable medical professionals, universities, hospitals, and pharmaceutical companies to visualize and measure biochemical processes at a molecular level.

Their range of products includes multi-modality brain imaging systems and solutions with ultra-compact scanner footprints and exceptional resolution, sensitivity, and image quality. These products are used for preclinical drug development, disease research in oncology and neurodegenerative diseases, and multimodal tracer development. Cubresa strongly values collaboration, partnership, and teamwork.

They strive for excellence and utmost quality in all their activities, along with efficient manufacturing, exemplary customer service, and support. Their culture is based on integrity, empowerment, diversity, and a passion for solving difficult scientific and societal problems. Based in Winnipeg, Canada, Cubresa is a world leader in designing and developing clinical and preclinical PET inserts for MRI.

Their commitment to quality and innovation has made them a trusted choice for medical professionals worldwide